Elefante Mark B Invests $4.53 Million in Xylem Inc. $XYL

Elefante Mark B purchased a new position in shares of Xylem Inc. (NYSE:XYLFree Report) during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 38,337 shares of the industrial products company’s stock, valued at approximately $4,532,000. Xylem makes up 2.0% of Elefante Mark B’s holdings, making the stock its 23rd largest holding.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Orion Porfolio Solutions LLC lifted its stake in shares of Xylem by 1.0% in the third quarter. Orion Porfolio Solutions LLC now owns 7,802 shares of the industrial products company’s stock valued at $1,151,000 after buying an additional 74 shares in the last quarter. Quest Investment Management LLC grew its stake in Xylem by 1.0% in the 3rd quarter. Quest Investment Management LLC now owns 7,588 shares of the industrial products company’s stock valued at $1,119,000 after purchasing an additional 77 shares during the period. Notis McConarty Edward raised its position in Xylem by 0.3% in the fourth quarter. Notis McConarty Edward now owns 31,678 shares of the industrial products company’s stock worth $4,314,000 after acquiring an additional 86 shares during the period. Moneco Advisors LLC raised its holdings in shares of Xylem by 4.6% in the 4th quarter. Moneco Advisors LLC now owns 2,049 shares of the industrial products company’s stock worth $279,000 after purchasing an additional 90 shares during the period. Finally, Compound Planning Inc. lifted its position in shares of Xylem by 4.2% during the 4th quarter. Compound Planning Inc. now owns 2,258 shares of the industrial products company’s stock valued at $308,000 after buying an additional 91 shares during the last quarter. 87.96% of the stock is owned by institutional investors.

Xylem Price Performance

Shares of NYSE:XYL opened at $113.62 on Monday. Xylem Inc. has a fifty-two week low of $105.29 and a fifty-two week high of $154.27. The company has a debt-to-equity ratio of 0.23, a quick ratio of 1.24 and a current ratio of 1.61. The business has a 50-day simple moving average of $118.04 and a two-hundred day simple moving average of $119.67. The firm has a market cap of $26.53 billion, a price-to-earnings ratio of 27.05, a price-to-earnings-growth ratio of 1.57 and a beta of 1.02.

Xylem (NYSE:XYLGet Free Report) last posted its quarterly earnings data on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.34 by $0.12. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The company had revenue of $2.34 billion for the quarter, compared to the consensus estimate of $2.34 billion. During the same quarter last year, the firm posted $1.26 earnings per share. The firm’s revenue was up 1.5% compared to the same quarter last year. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. On average, analysts expect that Xylem Inc. will post 5.67 earnings per share for the current year.

Xylem Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, September 24th. Investors of record on Thursday, August 27th will be paid a dividend of $0.43 per share. The ex-dividend date of this dividend is Thursday, August 27th. This represents a $1.72 dividend on an annualized basis and a yield of 1.5%. Xylem’s dividend payout ratio is presently 40.95%.

Analyst Ratings Changes

A number of analysts recently issued reports on the company. Robert W. Baird boosted their price objective on Xylem from $163.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, July 29th. CLSA upgraded Xylem to a “hold” rating in a research report on Thursday, June 25th. Jefferies Financial Group upgraded shares of Xylem from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $130.00 to $140.00 in a report on Thursday, June 25th. Barclays increased their target price on Xylem from $154.00 to $159.00 and gave the company an “overweight” rating in a report on Wednesday, July 29th. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Xylem in a research report on Wednesday, August 5th. Nine research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company. According to MarketBeat, Xylem currently has a consensus rating of “Moderate Buy” and a consensus target price of $154.23.

Check Out Our Latest Stock Analysis on Xylem

Xylem Profile

(Free Report)

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.

Featured Stories

Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYLFree Report).

Institutional Ownership by Quarter for Xylem (NYSE:XYL)

Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.